Themis Medicare Share Price

NSE: THEMISMED

₹ 110.64

+₹2.85 (2.64%)

Last updated 24 Jul, 2026, 15:29 IST

Themis Medicare Share Price Today

As of 25 Jul 2026, Themis Medicare share price is ₹110.64. The stock opened at ₹107.30, compared to its previous close of ₹107.79. During today's trading session, Themis Medicare share price moved in the range of ₹106.23 to ₹110.70, with an average price of ₹108.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹64.95 and a high of ₹148.00. On the performance front, Themis Medicare share price has increased by 37.86% over the last six months and is down 6.81% on a year-on-year basis.

₹106.23

2.64% up today

₹110.70

1D LOW

1D HIGH

Latest Earning

Op Profit TrendDown by 12.80% QoQ

Latest Earning

Net Profit TrendDown by 11.89% QoQ

Latest Earning

Revenue TrendDown by 12.26% QoQ

Stock Performance

OutperformingBeat Nifty by 11.91 % in last 3 month

Shareholding Pattern

DIIDII increased stake by 0.88%

Shareholding Pattern

FIIFII decreased stake by 91.03%

Themis Medicare Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,73,144-₹26,856 (-5.37%)

3 Year

₹3,79,815-₹1,20,185 (-24.04%)

5 Year

₹5,98,378+₹98,378 (+19.68%)

₹86.24₹129.34

Circuit Low

Circuit High

₹64.95₹148.00

52-Week Low

52-Week High

Circuit

₹86.24

₹129.34

52-week

₹64.95

₹148.00

Mkt Cap Cr

994.22

P/E

899.58

P/B

2.72

ROE

0.42%

D/E

0.33

ROCE

2.70%

Div. Yield

0.46%

EPS(TTM)

-1.54

Turnover

1.02

EV/EBITDA

47.42

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.19%

Quick Ratio

0.00

Curr. Ratio

3.47

Mkt Cap Cr

994.22

P/E

899.58

P/B

2.72

ROE

0.42%

D/E

0.33

ROCE

2.70%

Div. Yield

0.46%

EPS(TTM)

-1.54

Turnover

1.02

EV/EBITDA

47.42

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.19%

Quick Ratio

0.00

Curr. Ratio

3.47

Based on fundamentals, this stock's

Performance

Very Poor

Themis Medicare has not beaten FD return of 7%

Valuation

Overvalued

Themis Medicare appears overvalued compared to its peers

Earnings

Very Poor

Themis Medicare revenue, operating profits and net profits have been degrowing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,68,842.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72

Themis Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹405.51	₹381.76	₹354.32	₹394.61
Other Income	₹4.67	₹4.76	₹11.50	₹6.54
Total Revenue	₹410.18	₹386.52	₹365.83	₹401.16
Total Expenses	₹376.43	₹351.88	₹306.93	₹317.23
Profit Before Tax	₹39.67	₹53.44	₹72.51	₹95.26
Tax	₹9.84	₹9.92	₹15.61	₹22.38
Profit After Tax	₹29.83	₹43.52	₹56.90	₹72.88
EPS - Basic	₹3.24	₹4.73	₹6.18	₹79.22
EPS - Diluted	₹3.24	₹4.72	₹6.17	₹79.07

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹39.67	₹53.44	₹72.51	₹95.26
Income before WC changes	₹50.57	₹51.97	₹72.54	₹95.02
Change in Assets	-₹14.31	-₹31.83	-₹56.66	-₹28.96
Change in Liabilities	₹9.20	₹10.91	₹16.36	-₹13.59
Change in WC	-₹5.11	-₹20.92	-₹40.30	-₹42.55
Cash flow from Operations	₹34.71	₹22.09	₹16.09	₹34.39
Cash flow from Investing	-₹12.17	-₹15.95	-₹23.96	-₹15.59
Cash flow from Financing	-₹25.90	-₹8.77	₹0.14	-₹17.55
Total Cash Flow	-₹3.36	-₹2.62	-₹7.73	₹1.26
Cash (Start of the year)	₹9.92	₹12.55	₹20.28	₹19.02
Cash (End of the year)	₹6.56	₹9.92	₹12.55	₹20.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹284.17	₹273.25	₹249.43	₹213.62
Current Assets	₹303.87	₹293.17	₹264.53	₹214.16
Total Assets	₹588.03	₹566.42	₹513.96	₹427.78
Current Liabilities	₹156.12	₹154.58	₹139.13	₹109.52
Net Current Asset	₹147.74	₹138.58	₹125.40	₹104.64
Non-Current Liabilities	₹29.31	₹34.17	₹35.39	₹30.77
Equity Capital	₹402.60	₹377.67	₹339.44	₹287.49
Total Equity & Liabilities	₹588.03	₹566.42	₹513.96	₹427.78

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹405.51	₹381.76	₹354.32	₹394.61
Other Income	₹4.67	₹4.76	₹11.50	₹6.54
Total Revenue	₹410.18	₹386.52	₹365.83	₹401.16
Total Expenses	₹376.42	₹351.85	₹306.92	₹317.22
Profit Before Tax	₹33.76	₹34.67	₹58.91	₹83.94
Tax	₹9.84	₹9.92	₹15.61	₹22.38
Profit After Tax	₹23.92	₹24.75	₹43.29	₹61.56
EPS - Basic	₹2.60	₹2.69	₹4.70	₹66.91
EPS - Diluted	₹2.59	₹2.68	₹4.70	₹66.78

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹33.76	₹34.67	₹58.91	₹83.94
Income before WC changes	₹50.58	₹51.99	₹72.57	₹95.04
Change in Assets	-₹14.32	-₹31.89	-₹56.68	-₹28.98
Change in Liabilities	₹9.20	₹10.91	₹16.34	-₹13.59
Change in WC	-₹5.12	-₹20.99	-₹40.34	-₹42.57
Cash flow from Operations	₹34.71	₹22.04	₹16.07	₹34.39
Cash flow from Investing	-₹12.17	-₹15.96	-₹23.96	-₹15.58
Cash flow from Financing	-₹25.90	-₹8.77	₹0.14	-₹17.55
Total Cash Flow	-₹3.36	-₹2.68	-₹7.75	₹1.26
Cash (Start of the year)	₹9.83	₹12.51	₹20.27	₹19.00
Cash (End of the year)	₹6.47	₹9.83	₹12.51	₹20.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹200.50	₹195.52	₹190.49	₹168.32
Current Assets	₹305.15	₹294.44	₹265.80	₹215.42
Total Assets	₹505.65	₹489.97	₹456.29	₹383.74
Current Liabilities	₹156.06	₹152.92	₹139.07	₹109.48
Net Current Asset	₹149.09	₹141.52	₹126.72	₹105.94
Non-Current Liabilities	₹29.31	₹35.77	₹35.39	₹30.77
Equity Capital	₹320.29	₹301.28	₹281.83	₹243.48
Total Equity & Liabilities	₹505.65	₹489.97	₹456.29	₹383.74

* All values are in INR Crore

Qty

Bid

109.86

Ask

Qty

Bid Total: 25

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

48.88

Neutral

ATR (14)

5.64

Neutral

STOCH(9,6)

29.86

Neutral

STOCH RSI (14)

31.58

Neutral

ADX(9)

19.97

Bullish

UO(9)

35.04

Neutral

ROC(12)

-1.11

Bearish

WillR(14)

-74.45

Neutral

Period

Simple value

Exponential vaue

110.44

110.33

10D

112.31

111.58

20D

113.82

112.02

50D

108.55

108.04

100D

96.86

103.22

About Themis Medicare

ISIN

INE083B01024

Sector Market Cap

₹ 994.22 Cr

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.

Themis Medicare Financial Highlights

Revenue: Themis Medicare reported revenue of ₹351.60 crore in FY26 vs ₹410.18 crore in FY25. It showed a decrease of 14.28% on a yearly basis.
Operating Profit: Themis Medicare reported an operating profit of ₹1.93 crore in FY26 vs ₹39.67 crore in FY25. It showed a decrease of 95.13% on a year-on-year basis.
Net Profit: Themis Medicare reported a net profit of ₹1.14 crore in FY26 vs ₹29.83 crore in FY25. It showed a decrease of 96.18% on a yearly basis.

Themis Medicare Quarterly Result Highlights

Themis Medicare reported revenue of ₹80.20 crore in Mar 2026, compared with ₹91.41 crore in Dec 2025, representing a decrease of 12.26% on a quarter-on-quarter (QoQ) basis.
Themis Medicare reported an operating profit of ₹9.06 crore in Mar 2026, compared with ₹10.39 crore in Dec 2025, representing a decrease of 12.80% on a quarter-on-quarter (QoQ) basis.
Themis Medicare reported a profit of ₹8.89 crore in Mar 2026, compared with ₹10.09 crore in Dec 2025, reflecting a decrease of 11.89% on a QoQ basis.
The earnings per share (EPS) of Themis Medicare stood at ₹3.24 during Mar 2026.